Ultragenyx Pharmaceutical Inc. buy Evercore ISI
Start price
06.06.23
/
50%
€48.20
Target price
06.06.24
€74.95
Performance (%)
-20.33%
End price
07.06.24
€38.40
Summary
This prediction ended on 07.06.24 with a price of €38.40. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -20.33%. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -4.325% | -4.325% | -10.806% | -35.322% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by Evercore_ISI for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten